These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 15678597)

  • 21. Toxicogenomics: a pivotal piece in the puzzle of toxicological research.
    Gatzidou ET; Zira AN; Theocharis SE
    J Appl Toxicol; 2007; 27(4):302-9. PubMed ID: 17429800
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Toxicogenomics: A 2020 Vision.
    Liu Z; Huang R; Roberts R; Tong W
    Trends Pharmacol Sci; 2019 Feb; 40(2):92-103. PubMed ID: 30594306
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The importance of applying toxicogenomics to increase the efficiency of drug discovery.
    Barros SA
    Pharmacogenomics; 2005 Sep; 6(6):547-50. PubMed ID: 16142994
    [No Abstract]   [Full Text] [Related]  

  • 24. Consensus recommendations to promote and advance predictive systems toxicology and toxicogenomics.
    Waters M; Yauk C
    Environ Mol Mutagen; 2007 Jun; 48(5):400-3. PubMed ID: 17567851
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Toxicogenetics and toxicogenomics. Relevance and application in occupational health].
    Schulz T
    Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2006 Oct; 49(10):1004-10. PubMed ID: 17013775
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Whole genome transcript profiling of drug induced steatosis in rats reveals a gene signature predictive of outcome.
    Sahini N; Selvaraj S; Borlak J
    PLoS One; 2014; 9(12):e114085. PubMed ID: 25470483
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Integrating toxicogenomics into human health risk assessment: lessons learned from the benzo[a]pyrene case study.
    Chepelev NL; Moffat ID; Labib S; Bourdon-Lacombe J; Kuo B; Buick JK; Lemieux F; Malik AI; Halappanavar S; Williams A; Yauk CL
    Crit Rev Toxicol; 2015 Jan; 45(1):44-52. PubMed ID: 25605027
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Molecular responses to xenoestrogens: mechanistic insights from toxicogenomics.
    Moggs JG
    Toxicology; 2005 Oct; 213(3):177-93. PubMed ID: 15996808
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Is it safe?
    Doull J
    Vet Hum Toxicol; 1996 Dec; 38(6):456-8. PubMed ID: 8948081
    [No Abstract]   [Full Text] [Related]  

  • 30. Use of toxicogenomics to understand mechanisms of drug-induced hepatotoxicity during drug discovery and development.
    Blomme EA; Yang Y; Waring JF
    Toxicol Lett; 2009 Apr; 186(1):22-31. PubMed ID: 18996174
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The use of toxicogenomic data in risk assessment: a regulatory perspective.
    Chan VS; Theilade MD
    Clin Toxicol (Phila); 2005; 43(2):121-6. PubMed ID: 15822767
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Acute hepatotoxicity: a predictive model based on focused illumina microarrays.
    Zidek N; Hellmann J; Kramer PJ; Hewitt PG
    Toxicol Sci; 2007 Sep; 99(1):289-302. PubMed ID: 17522070
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The introduction of toxicogenomics; potential new markers of hepatotoxicity.
    Heijne WH; Stierum RH; Leeman WR; van Ommen B
    Cancer Biomark; 2005; 1(1):41-57. PubMed ID: 17192031
    [No Abstract]   [Full Text] [Related]  

  • 34. Prediction of human genes and diseases targeted by xenobiotics using predictive toxicogenomic-derived models (PTDMs).
    Cheng F; Li W; Zhou Y; Li J; Shen J; Lee PW; Tang Y
    Mol Biosyst; 2013 Jun; 9(6):1316-25. PubMed ID: 23455869
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Systems toxicology: applications of toxicogenomics, transcriptomics, proteomics and metabolomics in toxicology.
    Heijne WH; Kienhuis AS; van Ommen B; Stierum RH; Groten JP
    Expert Rev Proteomics; 2005 Oct; 2(5):767-80. PubMed ID: 16209655
    [TBL] [Abstract][Full Text] [Related]  

  • 36. In pursuit of effective toxicogenomics.
    Gant TW; Zhang SD
    Mutat Res; 2005 Aug; 575(1-2):4-16. PubMed ID: 15885710
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Application of toxicogenomics to genetic toxicology risk assessment.
    Thybaud V; Le Fevre AC; Boitier E
    Environ Mol Mutagen; 2007 Jun; 48(5):369-79. PubMed ID: 17567850
    [TBL] [Abstract][Full Text] [Related]  

  • 38. SimuGen Ltd: reliable, early prediction of drug toxicity with toxicogenomics, human cell culture and computational models.
    Wills Q
    Pharmacogenomics; 2007 Aug; 8(8):1081-4. PubMed ID: 17716240
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A New Approach in Applying Systems Engineering Tools and Analysis to Determine Hepatocyte Toxicogenomics Risk Levels to Human Health.
    Gigrich J; Sarkani S; Holzer T
    J Comput Biol; 2017 Mar; 24(3):238-254. PubMed ID: 27386833
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Toxicogenomics in risk assessment: applications and needs.
    Boverhof DR; Zacharewski TR
    Toxicol Sci; 2006 Feb; 89(2):352-60. PubMed ID: 16221963
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.